HIG
75
4
VRSN
58
2
NOV
55
-4
ETR
72
3
HCA
48
2
GILD
54
3
STX
55
-2
AMGN
31
-16
XOM
40
-7
BRK.B
45
2
SJM
45
9
PNW
70
3
HCP
62
-8
NWSA
63
-4
RIG
55
-6
OKE
78
3
RL
80
2
MHK
50
-5
IRM
52
2
LYB
41
-2
HIG
75
4
VRSN
58
2
NOV
55
-4
ETR
72
3
HCA
48
2
GILD
54
3
STX
55
-2
AMGN
31
-16
XOM
40
-7
BRK.B
45
2
SJM
45
9
PNW
70
3
HCP
62
-8
NWSA
63
-4
RIG
55
-6
OKE
78
3
RL
80
2
MHK
50
-5
IRM
52
2
LYB
41
-2
Financhill
Back

Aurelius Equity Opportunities Se & Co KGaA Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
23

AULRF
Aurelius Equity Opportunities Se & Co KGaA

Last Price:
18.94
Seasonality Move:
-21.27%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
130.47
Seasonality Move:
14.88%
Sell
23
Aurelius Equity Opportunities Se & Co KGaA (AULRF) is a Sell

Is Aurelius Equity Opportunities Se & Co KGaA a Buy, Sell or Hold?

  • The current Aurelius Equity Opportunities Se & Co KGaA [AULRF] share price is $18.94. The Score for AULRF is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • AULRF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AULRF Stock Price Chart

What is Aurelius Equity Opportunities Se & Co KGaA's stock price today?

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

AULRF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Sell
Relative Strength Index (14 RSI): 0 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.94 - 18.94) Sell
Bollinger Bands (100): (18.94 - 18.94) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

AULRF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.94 Sell
20-day SMA: 18.94 Sell
50-day SMA: 18.94 Sell
200-day SMA: 18.94 Sell
8-day EMA: 18.94 Sell
20-day EMA: 18.94 Sell
50-day EMA: 18.94 Sell
200-day EMA: 18.99 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Aurelius Equity Opportunities Se & Co KGaA Earnings Growth & AULRF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Aurelius Equity Opportunities Se & Co KGaA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):